{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T10:50:16Z","timestamp":1792839016638,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.ygyno.2009.12.008","type":"journal-article","created":{"date-parts":[[2009,12,30]],"date-time":"2009-12-30T04:13:10Z","timestamp":1262146390000},"page":"395-398","source":"Crossref","is-referenced-by-count":69,"title":["Does the use of diagnostic PET\/CT cause stage migration in patients with primary advanced ovarian cancer?"],"prefix":"10.1016","volume":"116","author":[{"given":"S.","family":"Risum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"H\u00f8gdall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Loft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.K.","family":"Berthelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"H\u00f8gdall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Nedergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Lundvall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.A.","family":"Engelholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2009.12.008_bib1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0020-7292(06)60033-7","article-title":"Carcinoma of the ovary. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer","volume":"95","author":"Heintz","year":"2006","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.ygyno.2009.12.008_bib2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ygyno.2006.11.022","article-title":"The diagnostic value of PET\/CT for primary ovarian cancer\u2014a prospective study","volume":"105","author":"Risum","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2009.12.008_bib3","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1102\/1470-7330.2006.9012","article-title":"PET\/CT: will it change the way that we use CT in cancer imaging?","volume":"6","author":"Hicks","year":"2006","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.ygyno.2009.12.008_bib4","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1007\/s00259-008-0890-2","article-title":"Diagnostic accuracy of integrated FDG-PET\/contrast-enhanced CT in staging ovarian cancer: comparison with enhanced CT","volume":"35","author":"Kitajima","year":"2008","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.ygyno.2009.12.008_bib5","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1056\/NEJM198506203122504","article-title":"The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer","volume":"312","author":"Feinstein","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2009.12.008_bib6","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/00006250-199903000-00028","article-title":"The risk-of-malignancy index to evaluate potential ovarian cancers in local hospitals","volume":"93","author":"Tingulstad","year":"1999","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2009.12.008_bib7","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2307\/2281868","article-title":"Non-parametric estimation for incomplete observations","volume":"53","author":"Kaplan","year":"1959","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.ygyno.2009.12.008_bib8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables","volume":"34","author":"Cox","year":"1972","journal-title":"J. R. Stat. Soc. B."},{"key":"10.1016\/j.ygyno.2009.12.008_bib9","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1200\/JCO.2003.02.051","article-title":"Role of docetaxel in the treatment of newly diagnosed advanced ovarian cancer","volume":"21","author":"Vasey","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2009.12.008_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/gyno.1996.4550","article-title":"Stage IV ovarian cancer: impact of surgical debulking","volume":"64","author":"Curtin","year":"1997","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2009.12.008_bib11","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1006\/gyno.1996.4396","article-title":"Effect of surgical debulking on survival in stage IV ovarian cancer","volume":"64","author":"Liu","year":"1997","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2009.12.008_bib12","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1200\/JCO.1999.17.3.767","article-title":"Natural history of stage IV epithelial ovarian cancer","volume":"17","author":"Bonnefoi","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2009.12.008_bib13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejogrb.2008.12.015","article-title":"Gynecologic Cancer Intergroup (GCIG) proposals for changes of the current FIGO staging system","volume":"143","author":"Petru","year":"2009","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.ygyno.2009.12.008_bib14","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1006\/gyno.1998.5145","article-title":"Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer","volume":"72","author":"Bristow","year":"1999","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2009.12.008_bib15","first-page":"101","article-title":"Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma","volume":"42","author":"Griffiths","year":"1975","journal-title":"Natl. Cancer. Inst. Monogr."},{"key":"10.1016\/j.ygyno.2009.12.008_bib16","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0090-8258(90)90042-J","article-title":"Tumor reduction surgery and long-term survival in advanced ovarian cancer: a DACOVA study","volume":"38","author":"Bertelsen","year":"1990","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2009.12.008_bib17","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0002-9378(94)70090-7","article-title":"The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma","volume":"170","author":"Hoskins","year":"1994","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2009.12.008_bib18","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/gyno.1998.4955","article-title":"Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study","volume":"69","author":"Eisenkop","year":"1998","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2009.12.008_bib19","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ygyno.2006.07.004","article-title":"\u201cOptimal\u201d cytoreduction for advanced epithelial ovarian cancer: a commentary","volume":"103","author":"Eisenkop","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2009.12.008_bib20","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0090-8258(03)00278-6","article-title":"Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study","volume":"90","author":"Eisenkop","year":"2003","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2009.12.008_bib21","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ygyno.2006.03.051","article-title":"What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?","volume":"103","author":"Chi","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2009.12.008_bib22","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.ygyno.2006.06.028","article-title":"The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer","volume":"103","author":"Eisenhauer","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2009.12.008_bib23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/01.AOG.0000192407.04428.bb","article-title":"Aggressive surgical effort and improved survival in advanced-stage ovarian cancer","volume":"107","author":"Aletti","year":"2006","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2009.12.008_bib24","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ygyno.2005.08.027","article-title":"Surgical treatment of diaphragm disease correlates with improved survival in optimally debulked advanced stage ovarian cancer","volume":"100","author":"Aletti","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2009.12.008_bib25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ygyno.2007.02.026","volume":"106","author":"Wimberger","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2009.12.008_bib26","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ygyno.2006.10.055","article-title":"Analysis of factors impacting operability in stage IV ovarian cancer: rationale use of a triage system","volume":"105","author":"Aletti","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2009.12.008_bib27","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1006\/gyno.1998.5213","article-title":"Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients","volume":"71","author":"Vergote","year":"1998","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2009.12.008_bib28","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1002\/1097-0142(20011115)92:10<2585::AID-CNCR1611>3.0.CO;2-#","article-title":"Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics Stage IIIC ovarian carcinoma","volume":"92","author":"Kuhn","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2009.12.008_bib29","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1002\/1097-0142(20010615)91:12<2329::AID-CNCR1265>3.0.CO;2-U","article-title":"Neoadjuvant chemotherapy for unresectable ovarian carcinoma: a French multicenter study","volume":"91","author":"Ansquer","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2009.12.008_bib30","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jamcollsurg.2003.06.004","article-title":"Results of interval debulking surgery compared with primary debulking surgery in advanced stage ovarian cancer","volume":"197","author":"Morice","year":"2003","journal-title":"J. Am. Coll. Surg."},{"key":"10.1016\/j.ygyno.2009.12.008_bib31","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ajog.2006.03.075","article-title":"Initial chemotherapy followed by surgical cytoreduction for the treatment of stage III\/IV epithelial ovarian cancer","volume":"195","author":"Everett","year":"2006","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2009.12.008_bib32","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.ygyno.2006.06.025","article-title":"Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: a meta-analysis","volume":"103","author":"Bristow","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2009.12.008_bib33","unstructured":"European Organization for Research and Treatment of Cancer: Randomized phase III study comparing upfront debulking surgery versus neo-adjuvant chemotherapy in patients with stage IIIc or IV epithelial ovarian cancer (EORTC protocol 55971). (http:\/\/www eortc be\/protoc\/Details asp?Protocol=55971) 2008."},{"key":"10.1016\/j.ygyno.2009.12.008_bib34","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0140-6736(00)03590-X","article-title":"Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma","volume":"357","author":"Vergote","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2009.12.008_bib35","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/jnci\/95.2.113","article-title":"Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial","volume":"95","author":"Trimbos","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2009.12.008_bib36","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1046\/j.1525-1438.1993.03040211.x","article-title":"Prognostic factors and adjuvant treatment in early epithelial ovarian cancer","volume":"3","author":"Bertelsen","year":"1993","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2009.12.008_bib37","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1200\/JCO.2007.11.1013","article-title":"Adjuvant chemotherapy for early-stage ovarian cancer: review of the literature","volume":"25","author":"Trope","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2009.12.008_bib38","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/cncr.24149","volume":"115","author":"du Bois","year":"2009","journal-title":"Cancer"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825809009901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825809009901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T07:08:47Z","timestamp":1739689727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825809009901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0090825809009901"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2009.12.008","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}